Author

Erin Flynt

ORCID 0000-0002-1524-6156Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:benchmark study· 1 Research Focus:cancer & tumor microenvironment· 1 Organism:human· 1 Approach:statistical model· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Alessandro LaganàiD· 1 shared Angela Hamblin· 1 shared Anjan ThakurtaiD· 1 shared Evie Fitzsimons· 1 shared Hervé Avet‐LoiseauiD· 1 shared Jill CorreiD· 1 shared Karthik RamasamyiD· 1 shared Kwee YongiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alessandro LaganàORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMay 21, 2026

Sequential acquisition of 1p31.1-p12 LOH and 1q Gain is a common double-hit event in relapsed/refractory myeloma

Naser Ansari‐Pour, Sarah Gooding, Mohammad H. Kazeroun…·Anjan Thakurta

The paper identifies a therapy-driven genomic double-hit (1pCEN LOH and 1q gain) in relapsed/refractory myeloma, associated with poor prognosis and clonal expansion.

DOI 10.64898/2026.05.19.726252

humanwhole-genome sequencing

𝕏 PostBluesky